NightstaRx completes venture financing

NightstaRx Ltd., London, U.K. Business: Gene/Cell therapy, Ophthalmic Date completed: 1/30/14 Type: Venture financing Raised: £12 million ($19.8 million) Investor: Syncona Partners ...